Natera Files Patent Infringement Suit Against NeoGenomics Labs For Infringement Of Natera's U.S. Patent Numbers. 11,519,035 And 11,530,454 By Neogenomics' Radar Molecular Residual Disease Assay
Portfolio Pulse from Happy Mohamed
Natera, Inc. (NASDAQ:NTRA) has filed a patent infringement lawsuit against NeoGenomics Labs, Inc. for infringement of Natera's U.S. Patent Nos. 11,519,035 and 11,530,454 by NeoGenomics' RaDaR molecular residual disease assay. This follows a recent jury verdict in favor of Natera in a similar patent infringement suit against ArcherDX/Invitae Corp.
July 31, 2023 | 5:40 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NeoGenomics Labs is facing a patent infringement lawsuit from Natera, which could potentially lead to financial losses if they lose.
The lawsuit could potentially lead to financial losses for NeoGenomics if they lose, which could negatively impact their stock price. However, the outcome of the lawsuit is uncertain and legal proceedings can be lengthy and costly.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Natera has filed a patent infringement lawsuit against NeoGenomics Labs, which could potentially lead to financial gains if they win.
The lawsuit could potentially lead to financial gains for Natera if they win, which could positively impact their stock price. However, the outcome of the lawsuit is uncertain and legal proceedings can be lengthy and costly.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100